/SEQUA.BR
SEQUA.BR Stock - Sequana Medical N.V.
Healthcare|Medical - DevicesBRU
$0.65-4.67%
$0.03 (-4.67%) • Dec 24
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.6
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.72
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SEQUA.BR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.65 – $0.66
TARGET (TP)$0.75
STOP LOSS$0.60
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.34
52W High$4.39
52W Low$0.58
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $106,000 | $712,173 | $922,687 | $370,500 | $963,280 |
| Gross Profit | $-2,218,000 | $548,049 | $718,090 | $293,837 | $760,869 |
| Gross Margin | -2092.5% | 77.0% | 77.8% | 79.3% | 79.0% |
| Operating Income | $-18,706,000 | $-29,491,472 | $-28,094,485 | $-22,649,299 | $-17,454,495 |
| Net Income | $-44,654,000 | $-32,563,574 | $-30,763,084 | $-23,615,080 | $-19,106,205 |
| Net Margin | -42126.4% | -4572.4% | -3334.1% | -6373.8% | -1983.5% |
| EPS | $-1.22 | $-1.22 | $-1.35 | $-1.30 | $-1.25 |
Company Overview
Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SEQUA.BRBeat Rate
0%
Last 5 quarters
Avg Surprise
-196.8%
EPS vs Estimate
Beats / Misses
0/5
Last 12 quarters
Latest EPS
$-0.35
Q3 2025
EPS Surprise History
Q3 23
No data
Q4 23
No data
Q1 24
-96.6%
$-0.57vs$-0.29
Q2 24
No data
Q4 24
-126.7%
$-0.34vs$-0.15
Q4 24
No data
Q1 25
-541.7%
$-0.77vs$-0.12
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 8, 2026 | — | — | — | — |
Q3 2025 | Sep 25, 2025 | — | $-0.35 | — | — |
Q1 2025 | Mar 18, 2025 | $-0.12 | $-0.77 | -541.7% | ✗ MISS |
Q4 2024 | Dec 31, 2024 | — | $-0.82 | — | — |
Q4 2024 | Oct 24, 2024 | $-0.15 | $-0.34 | -126.7% | ✗ MISS |
Q2 2024 | Jun 30, 2024 | — | $-0.34 | — | — |
Q1 2024 | Mar 28, 2024 | $-0.29 | $-0.57 | -96.6% | ✗ MISS |
Q4 2023 | Dec 31, 2023 | — | $-0.57 | — | — |
Q3 2023 | Sep 14, 2023 | — | $-0.65 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.65 | — | — |
Q1 2023 | Feb 9, 2023 | $-0.32 | $-0.67 | -109.2% | ✗ MISS |
Q2 2022 | Jun 30, 2022 | — | $-0.68 | — | — |
Q2 2022 | Apr 12, 2022 | $-0.30 | $-0.63 | -110.0% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $-0.63 | — | — |
Q3 2021 | Sep 2, 2021 | — | $-0.66 | — | — |
Q1 2021 | Mar 17, 2021 | — | — | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.62 | — | — |
Q3 2020 | Sep 3, 2020 | — | $-0.62 | — | — |
Q1 2020 | Mar 19, 2020 | — | — | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.61 | — | — |
Latest News
Loading news...
Frequently Asked Questions about SEQUA.BR
What is SEQUA.BR's current stock price?
Sequana Medical N.V. (SEQUA.BR) is currently trading at $0.65 per share. The stock has moved -4.67% today.
What is the analyst price target for SEQUA.BR?
No analyst price targets are currently available for this stock.
What sector is Sequana Medical N.V. in?
Sequana Medical N.V. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the BRU exchange.
What is SEQUA.BR's market cap?
Sequana Medical N.V. has a market capitalization of $0.05 billion, making it a small-cap company.
Does SEQUA.BR pay dividends?
No, Sequana Medical N.V. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorARGX.BR
argenx SE
$718.60
Mkt Cap: $44.0B
IBAB.BR
Ion Beam Applications S.A.
$12.14
Mkt Cap: $0.4B
LUNG
Pulmonx Corporation
$2.28
Mkt Cap: $0.1B
OXUR.BR
Oxurion N.V.
$0.01
Mkt Cap: $0.0B
SEMHF
Siemens Healthineers AG
$52.23
Mkt Cap: $58.5B
SONX
Sonendo, Inc.
$0.13
Mkt Cap: $0.0B
Explore stocks similar to SEQUA.BR for comparison